Expression of microRNA-184 in glioma
- PMID: 29422963
- PMCID: PMC5772950
- DOI: 10.3892/ol.2017.7395
Expression of microRNA-184 in glioma
Abstract
The aim of the present study was to examine the expression of microRNA (miRNA)-184 in gliomas with different pathological grades, and its effect on survival prognosis. For the present study, 40 participants were selected with different pathological grades of glioma tissues with grade I (n=10), grade II (n=8), grade III (n=16), and grade IV (n=6). In addition, 10 cases of normal brain tissue (obtained by decompression because of traumatic brain injury) were selected. RT-PCR and immunohistochemical techniques were used to detect the expression level and intensity of miRNA-184 in different grades of glioma tissues. The length of survival of miRNA-184-positive patients was analyzed. miRNA-184 mRNA expression was found in normal tissues and tumor tissues, and the expression in tumor tissues was significant (P<0.05). Statistically significant differences of miRNA-184 expression were observed among different grades (P<0.05). miRNA-184 expression increased with the increase of grade level. The differences in expression across grade levels was statistically significant (P<0.05). A positive expression was not related to the pathological types of glioma cells. The median survival time of patients with miRNA-184-positive expression was significantly shorter than that of the negative expression group (P<0.05). miRNA-184 is highly expressed in gliomas, which is positively correlated with pathological grade, and is not correlated with pathological type, and negatively correlated with survival time. Thus, miRNA-184 is a potentially important molecular marker for glioma.
Keywords: RT-PCR method; glioma; immunohistochemistry; microRNA-184; pathological grade; survival time.
Figures



Similar articles
-
MicroRNA-200b expression level is negatively associated with pathological grading in human gliomas.Cancer Manag Res. 2018 Aug 24;10:2825-2834. doi: 10.2147/CMAR.S171137. eCollection 2018. Cancer Manag Res. 2018. PMID: 30197535 Free PMC article.
-
The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosis.Neurol Sci. 2017 Jan;38(1):67-73. doi: 10.1007/s10072-016-2710-y. Epub 2016 Sep 15. Neurol Sci. 2017. PMID: 27629767
-
Correlation of microRNA-372 upregulation with poor prognosis in human glioma.Diagn Pathol. 2013 Jan 8;8:1. doi: 10.1186/1746-1596-8-1. Diagn Pathol. 2013. PMID: 23298385 Free PMC article.
-
MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.J Clin Neurosci. 2014 May;21(5):755-60. doi: 10.1016/j.jocn.2013.06.024. Epub 2013 Sep 11. J Clin Neurosci. 2014. PMID: 24382515
-
DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.Int J Mol Sci. 2015 Jul 9;16(7):15578-91. doi: 10.3390/ijms160715578. Int J Mol Sci. 2015. PMID: 26184164 Free PMC article.
Cited by
-
microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance.Cell Death Discov. 2023 Nov 24;9(1):423. doi: 10.1038/s41420-023-01718-1. Cell Death Discov. 2023. PMID: 38001121 Free PMC article. Review.
-
Electroacupuncture protective effects after cerebral ischemia are mediated through miR-219a inhibition.Biol Res. 2023 Jun 30;56(1):36. doi: 10.1186/s40659-023-00448-z. Biol Res. 2023. PMID: 37391839 Free PMC article.
-
Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer.J Transl Med. 2018 May 21;16(1):131. doi: 10.1186/s12967-018-1515-6. J Transl Med. 2018. PMID: 29783999 Free PMC article.
References
-
- Pessina F, Navarria P, Cozzi L, Ascolese AM, Simonelli M, Santoro A, Tomatis S, Riva M, Fava E, Scorsetti M, et al. Value of surgical resection in patients with newly diagnosed grade III glioma treated in a multimodal approach: Surgery, chemotherapy and radiotherapy. Ann Surg Oncol. 2016;23:3040–3046. doi: 10.1245/s10434-016-5222-3. - DOI - PubMed
-
- Sehm T, Fan Z, Ghoochani A, Rauh M, Engelhorn T, Minakaki G, Dörfler A, Klucken J, Buchfelder M, Eyüpoglu IY, et al. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. Oncotarget. 2016;7:36021–36033. doi: 10.18632/oncotarget.8651. - DOI - PMC - PubMed
-
- Bush NA, Chang SM, Berger MS. Current and future strategies for treatment of glioma. Neurosurg Rev. 2016;16:7–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources